last posts

Global Messenger RNA (mRNA) Vaccines and Therapeutics Market Research Report 2022 with Pfizer, GSK, Daiichi Sankyo, Intellia Therapeutics, Moderna, CureVac, Arcturus Therapeutics and BioNTech

techsm5

company logo

company logo

Dublin, Jan. 05, 2023 (GLOBE NEWSWIRE) — The report “Messenger RNA (mRNA) Vaccines and Therapeutics Market Size, Global Forecast 2023-2028, Industry Trends, Growth, Inflation Impact, Analysis business opportunities” has been added to from ResearchAndMarkets.com offer.

Global Messenger RNA (mRNA) Vaccines and Therapeutics Market was valued at US$11.63 Billion in 2022 and is projected to reach US$26.34 Billion by 2028

Messenger ribonucleic acid (mRNA) is a term that refers to a single protein-coding gene in the genome that forms the basis of protein synthesis in cells. Vaccines and mRNA-based treatments are made in laboratories using mammalian cells and have favorable immunological characteristics.

mRNA vaccines for the prevention of infections, mRNA vaccines for the treatment of infectious diseases, personalized mRNA vaccines for the treatment of cancer, and standardization of mRNA vaccines for the treatment of cancer are common types of vaccinations and of therapies. They are injected into the body to activate immunological sensors that detect viruses and cause cells to generate viral antigenic proteins. This enhances B and T cell responses, which helps the body’s immunity.

Global Messenger RNA (mRNA) Vaccines and Therapeutics Market Size to Grow at a CAGR of 14.60% from 2022 to 2028

Vaccines and mRNA-based treatments are generated using new technologies that are more effective against infections, have higher potency, improved immunogenicity, and are relatively more cost-effective than conventional pharmaceuticals.

One of the critical factors propelling the development of the global messenger RNA (mRNA) vaccines and therapeutics market is the increased prevalence of medical conditions such as diabetes, tuberculosis, cancer, and cardiovascular disease (CVD).

In addition, the industry is also benefiting from the growing demand for therapeutic drugs and vaccines against Ebola, influenza, HIV and other viral diseases.

Evolution of the Global Messenger RNA (mRNA) Vaccines and Therapeutics Industry During the Pandemic

With the launch and widespread use of mRNA vaccines and therapies against COVID-19, 2020 marked a turning point for mRNA technology platforms. As a result, the combined market valuation of mRNA platforms had increased rapidly in 2020.

The increase in market value reflects expectations that mRNA technology will yield far more than current COVID-19 preventative vaccines.

Global Messenger RNA (mRNA) Vaccines and Therapeutics Market Segmentation Analysis:

By type, the market is split into mRNA Vaccine for Infection Prevention, mRNA Vaccine for Infectious Disease Treatment, mRNA Vaccine for Individualized Cancer Treatment, and standardization of mRNA Vaccine for Cancer Treatment.

By application, Cancer, Infectious Diseases and Others are the major segments covered in our report. According to our estimates, infectious diseases hold a major share of the market and are expected to remain dominant throughout the forecast period.

By end user, we studied the market for hospitals, clinics, diagnostic centers and others. According to our analysis, clinics and diagnostic centers are gaining momentum with the advancement of technological applications. However, hospitals tend to remain dominant throughout the study period.

By region, North America, Europe, Asia-Pacific and Rest of the world. During the forecast period, North America is estimated to monopolize the global messenger RNA (mRNA) vaccines and therapeutics market. The North America market is driven by an increase in demand for COVID-19 mRNA vaccines, major players operating in the United States, and an exponential rise in the number of COVID-19 cases in the United States.

Key players:

Pfizer, GlaxoSmithKline, Daiichi Sankyo Company, Limited, Intellia Therapeutics, Moderna Inc, CureVac NV, Arcturus Therapeutics Holdings, and BioNTech are the key companies in the global messenger RNA (mRNA) vaccines and therapeutics market examined in our analysis.

Additionally, we have discussed the competition landscape section of the study, which included an overview, latest development strategies, and market revenue analysis of the aforementioned global companies. Surprisingly, large companies are investing in mRNA technologies because they can integrate many molecules into a therapeutic drug, which is a huge growth driver.

Key players:

  • Pfizer

  • GlaxoSmithKline’s

  • Daiichi Sankyo Company, Limited.

  • Therapeutic Intellia

  • Moderna inc.

  • CureVac AG

  • Arcturus Therapeutics Holdings

  • BioNTech

Company information:

  • Insight

  • Recent development

  • Revenue

Main topics covered:

1. Introduction

2. Research and methodology

3. Executive Summary

4. Market dynamics
4.1 Drivers of growth
4.2 Challenges
4.3 Opportunities

5. Global Messenger RNA (mRNA) Vaccines and Therapeutics Market

6. Share Analysis – Global Messenger RNA (mRNA) Vaccines and Therapeutics Market
6.1 By type
6.2 By request
6.3 By the end user
6.4 By region

7. Type – Global Messenger RNA (mRNA) Vaccines and Therapeutics Market
7.1 mRNA vaccine for infection prevention
7.2 mRNA vaccine for the treatment of infectious diseases
7.3 Personalized mRNA vaccine for cancer treatment
7.4 Standardization of mRNA vaccine for cancer treatment

8. Application – Global Messenger RNA (mRNA) Vaccines and Therapeutics Market
8.1 Cancer
8.2 Infectious diseases
8.3 Others

9. End User – Global Messenger RNA (mRNA) Vaccines and Therapeutics Market
9.1 Hospital
9.2 Clinics
9.3 Diagnostic centers
9.4 Others

10. Region – Global Messenger RNA (mRNA) Vaccines and Therapeutics Market
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the world

11. Main actors

For more information about this report visit https://www.researchandmarkets.com/r/466t7z

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

techsm5

Comments



Font Size
+
16
-
lines height
+
2
-